513 related articles for article (PubMed ID: 35122827)
1. The role of NFATc1/c-myc/PKM2/IL-10 axis in activating cervical cancer tumor-associated M2 macrophage polarization to promote cervical cancer progression.
Tan J; Yang L; Zhao H; Ai Y; Ren L; Zhang F; Dong W; Shi R; Sun D; Feng Y
Exp Cell Res; 2022 Apr; 413(2):113052. PubMed ID: 35122827
[TBL] [Abstract][Full Text] [Related]
2. Wnt5a-induced M2 polarization of tumor-associated macrophages via IL-10 promotes colorectal cancer progression.
Liu Q; Yang C; Wang S; Shi D; Wei C; Song J; Lin X; Dou R; Bai J; Xiang Z; Huang S; Liu K; Xiong B
Cell Commun Signal; 2020 Mar; 18(1):51. PubMed ID: 32228612
[TBL] [Abstract][Full Text] [Related]
3. miR-195-5p/NOTCH2-mediated EMT modulates IL-4 secretion in colorectal cancer to affect M2-like TAM polarization.
Lin X; Wang S; Sun M; Zhang C; Wei C; Yang C; Dou R; Liu Q; Xiong B
J Hematol Oncol; 2019 Feb; 12(1):20. PubMed ID: 30808369
[TBL] [Abstract][Full Text] [Related]
4. Taraxacum mongolicum extract inhibited malignant phenotype of triple-negative breast cancer cells in tumor-associated macrophages microenvironment through suppressing IL-10 / STAT3 / PD-L1 signaling pathways.
Deng XX; Jiao YN; Hao HF; Xue D; Bai CC; Han SY
J Ethnopharmacol; 2021 Jun; 274():113978. PubMed ID: 33716082
[TBL] [Abstract][Full Text] [Related]
5. CPEB3 inhibits epithelial-mesenchymal transition by disrupting the crosstalk between colorectal cancer cells and tumor-associated macrophages via IL-6R/STAT3 signaling.
Zhong Q; Fang Y; Lai Q; Wang S; He C; Li A; Liu S; Yan Q
J Exp Clin Cancer Res; 2020 Jul; 39(1):132. PubMed ID: 32653013
[TBL] [Abstract][Full Text] [Related]
6. Astragaloside IV suppresses the migration and EMT progression of cervical cancer cells by inhibiting macrophage M2 polarization through TGFβ/Smad2/3 signaling.
Shen L; Li Y; Hu G; Song X; Wang X; Li X; Xu X
Funct Integr Genomics; 2023 Apr; 23(2):133. PubMed ID: 37081108
[TBL] [Abstract][Full Text] [Related]
7. The NR_109/FUBP1/c-Myc axis regulates TAM polarization and remodels the tumor microenvironment to promote cancer development.
Zhang C; Wei S; Dai S; Li X; Wang H; Zhang H; Sun G; Shan B; Zhao L
J Immunother Cancer; 2023 May; 11(5):. PubMed ID: 37217247
[TBL] [Abstract][Full Text] [Related]
8. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
9. Zoledronic acid inhibits thyroid cancer stemness and metastasis by repressing M2-like tumor-associated macrophages induced Wnt/β-catenin pathway.
Lv J; Chen FK; Liu C; Liu PJ; Feng ZP; Jia L; Yang ZX; Hou F; Deng ZY
Life Sci; 2020 Sep; 256():117925. PubMed ID: 32522570
[TBL] [Abstract][Full Text] [Related]
10. Extracellular vesicle-packaged miR-181c-5p from epithelial ovarian cancer cells promotes M2 polarization of tumor-associated macrophages via the KAT2B/HOXA10 axis.
Yang S; Zhao H; Xiao W; Shao L; Zhao C; Sun P
J Gene Med; 2022 Oct; 24(10):e3446. PubMed ID: 36027869
[TBL] [Abstract][Full Text] [Related]
11. The Effect of Salvianolic Acid A on Tumor-Associated Macrophage Polarization and Its Mechanisms in the Tumor Microenvironment of Triple-Negative Breast Cancer.
Tang C; Jiang ST; Li CX; Jia XF; Yang WL
Molecules; 2024 Mar; 29(7):. PubMed ID: 38611749
[TBL] [Abstract][Full Text] [Related]
12. Effects of IFN-γ on the immunological microenvironment and TAM polarity in stage IA non-small cell lung cancer and its mechanisms.
Zhao W; Wang H; Zhang X; Zhang L; Pu W; Ma Y; Chen W
BMC Pulm Med; 2024 Jan; 24(1):46. PubMed ID: 38254043
[TBL] [Abstract][Full Text] [Related]
13. Exosomal NOX1 promotes tumor-associated macrophage M2 polarization-mediated cancer progression by stimulating ROS production in cervical cancer: a preliminary study.
Gu L; Feng C; Li M; Hong Z; Di W; Qiu L
Eur J Med Res; 2023 Sep; 28(1):323. PubMed ID: 37679792
[TBL] [Abstract][Full Text] [Related]
14. CD133-containing microvesicles promote cancer progression by inducing M2-like tumor-associated macrophage polarization in the tumor microenvironment of colorectal cancer.
Kim SY; Park S; Kim S; Ko J
Carcinogenesis; 2024 May; 45(5):300-310. PubMed ID: 38085813
[TBL] [Abstract][Full Text] [Related]
15. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1.
Wen ZF; Liu H; Gao R; Zhou M; Ma J; Zhang Y; Zhao J; Chen Y; Zhang T; Huang F; Pan N; Zhang J; Fox BA; Hu HM; Wang LX
J Immunother Cancer; 2018 Dec; 6(1):151. PubMed ID: 30563569
[TBL] [Abstract][Full Text] [Related]
16. The role of the hypoxia-Nrp-1 axis in the activation of M2-like tumor-associated macrophages in the tumor microenvironment of cervical cancer.
Chen XJ; Wu S; Yan RM; Fan LS; Yu L; Zhang YM; Wei WF; Zhou CF; Wu XG; Zhong M; Yu YH; Liang L; Wang W
Mol Carcinog; 2019 Mar; 58(3):388-397. PubMed ID: 30362630
[TBL] [Abstract][Full Text] [Related]
17. Ovatodiolide suppresses colon tumorigenesis and prevents polarization of M2 tumor-associated macrophages through YAP oncogenic pathways.
Huang YJ; Yang CK; Wei PL; Huynh TT; Whang-Peng J; Meng TC; Hsiao M; Tzeng YM; Wu AT; Yen Y
J Hematol Oncol; 2017 Feb; 10(1):60. PubMed ID: 28241877
[TBL] [Abstract][Full Text] [Related]
18. 13-Methyl-palmatrubine shows an anti-tumor role in non-small cell lung cancer via shifting M2 to M1 polarization of tumor macrophages.
Wu Z; Zhou J; Chen F; Yu J; Li H; Li Q; Li W
Int Immunopharmacol; 2022 Mar; 104():108468. PubMed ID: 35066343
[TBL] [Abstract][Full Text] [Related]
19. The correlation between tumor-associated macrophage infiltration and progression in cervical carcinoma.
Guo F; Kong W; Zhao G; Cheng Z; Ai L; Lv J; Feng Y; Ma X
Biosci Rep; 2021 May; 41(5):. PubMed ID: 33928349
[TBL] [Abstract][Full Text] [Related]
20. Linc00514 promotes breast cancer metastasis and M2 polarization of tumor-associated macrophages via Jagged1-mediated notch signaling pathway.
Tao S; Chen Q; Lin C; Dong H
J Exp Clin Cancer Res; 2020 Sep; 39(1):191. PubMed ID: 32943090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
